OS Fund invests in entrepreneurs using applied intelligence to commercialize breakthrough discoveries in genomics, synthetic biology, diagnostics, new materials, and data and energy. We seek out platform enabling technologies that accelerate discovery and commercialization. We never invest in a single molecule, model or algorithm. We do hard science investing with technology level risk.
We work with our portfolio companies to develop foundational IP that solves real-world challenges and paves a path for commercialization. We’ve thoughtfully constructed a cross-disciplinary group of companies that are each uniquely contributing to the robust ecosystem they all need to thrive.
Location: United States, Illinois, Chicago
Employees: 1-10
Founded date: 2014
Investment Type: Venture Capital
Investment Stage: Series A
Portfolio 35
Date | Name | Website | Total Raised | Location |
21.11.2021 | Viridos | viridos.co... | $25M | United Sta... |
06.05.2021 | Aria Pharm... | ariapharma... | - | United Sta... |
17.07.2020 | Viv | viv.ai | $12.5M | United Sta... |
17.07.2020 | Health Dat... | healthdata... | - | - |
28.04.2020 | Kenota Hea... | kenota.com | $9M | Canada, On... |
19.03.2018 | twoXAR | twoxar.com | $13.4M | - |
29.11.2017 | Arzeda | arzeda.com | $60.2M | - |
13.12.2016 | Lygos | lygos.com | $50.5M | United Sta... |
- | Exvivo | exvivo.com | - | Canada, On... |
- | Nanoly | nanoly.inf... | - | - |
Show more
News 10
Date | Title | Description |
22.04.2021 | Q1 2021 Portfolio Company Updates: $9B increase in NIH fundi... | While the vaccine roll-out has helped us start our social normalization process, one thing that has ... |
08.01.2021 | Q4 2020 Portfolio Company Updates: The Biotech Revolution, C... | The seismic shifts of 2020 have sparked an acceleration of innovations which have armed humanity wit... |
22.10.2020 | Q3 2020 Portfolio Company Updates: Adaptability and Future L... | There is no doubt that the complex impact of the coronavirus pandemic has challenged us all to refle... |
- | The most incredible technology you’ve never seen | There’s money to be made and lives to be saved with the tiny stuff that’s all around us. Saving the ... |
- | OS Fund — Building A Global Biological Immune System | Increasing the probability that the human race will thrive. tl:dr After selling my company Braintree... |
- | Synthego: The One Stop Shop for Revolutionary Genetic Resear... | This article is part of a series about how OS Fund (OSF) companies are radically redefining our futu... |
- | A Lesson From SARS-CoV-2: We Need to Build A Real-Time Globa... | A coronavirus has ravaged our planet. Humanity brought to its knees by 29,829 nucleotides of “bad ne... |
- | Scaling AI-Driven Drug Discovery: twoXAR Signs Four Partners... | Last year we announced our investment in twoXAR, a company building a next generation drug discovery... |
- | Re-writing Nature’s Recipe Book: How Ginkgo Bioworks is Pois... | Ginkgo Bioworks, based in Boston, has been in the headlines lately: Ginkgo will “bring biodesign to ... |
- | Q2 2020 Portfolio Company Updates: The Fight Against COVID-1... | The second quarter was an unprecedented time in our history; and while much of the world remains in ... |
Mentions in press and media 26
Date | Title | Description | Source |
30.09.2021 | DNA-based data storage platform Catalog raises $35M | Conventional electronic media like flash drives and hard drives require energy consumption to proces... | techcrunch... |
24.09.2019 | A-Alpha Bio raises $2.8M for genetically engineered drug dis... | The A-Alpha Bio team includes scientist Emily Engelhart, principal scientist David Colby, co-founder... | geekwire.c... |
21.09.2018 | Biotech Startup uBiome Raises $83M to Expand World’s Largest... | uBiome, a microbial genetics company leveraging artificial intelligence to develop wellness products... | hitconsult... |
07.08.2018 | OS Fund to Raise $250M to Back Startups Solving Global Probl... | OS Fund, a Venice, CA-based venture capital firm that invests in entrepreneurs and companies that de... | finsmes.co... |
19.03.2018 | TwoXar raises $10 million from SoftBank, Andreessen Horowitz... | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn m... | venturebea... |
19.03.2018 | Bioinformatics startup twoXAR bags $10M in Series A | JP Lee, managing director of SoftBank Ventures, will join Andreessen Horowitz general partner Vijay ... | medcitynew... |
19.03.2018 | TwoXar raises $10 million from SoftBank, Andreessen Horowitz... | TwoXar, a biopharmaceutical startup that uses artificial intelligence (AI) to identify and develop n... | venturebea... |
30.11.2017 | UPDATE: Arzeda Closes Series A on $15.2m for Plant-Based Com... | *First published July 27, 2017. Updated November 30 to reflect final close on $15.2 million Seattle... | agfunderne... |
30.10.2017 | Five Startups Set to Disrupt Your Kid’s Halloween Candy | It’s a scary fact for any parent, particularly at bedtime tomorrow: children eat an average of three... | agfunderne... |
13.12.2016 | Synthetic biology startup Lygos raises $13 million from OS F... | Lygos uses microbugs to convert low-cost sugar into specialty chemicals used in manufacturing, and i... | techcrunch... |
Show more